Results 151 to 160 of about 8,267 (256)

The 2011 ACGME Program Requirements: A New Model for Quality and Safety [PDF]

, 2011
Caruso, John W., MD, FACP
core   +1 more source

An Exploration of the Interplay Between Caffeine and Antidepressants Through the Lens of Pharmacokinetics and Pharmacodynamics. [PDF]

Eur J Drug Metab Pharmacokinet
Truong J, Abu-Suriya N, Tory D, Bahho R, Ismaiel A, Nguyen T, Mansour A, Nand V, Saponja J, Dua K, De Rubis G, Parisi D.   +11 more
europepmc   +1 more source

Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice. [PDF]

Int J Mol Sci, 2023
Pilski A, Graves SM.
europepmc   +1 more source

AUTO‐POTENTIATION AND POTENTIATION BY INHIBITION OF MONOAMINE OXIDASE OF THE SYMPATHOMIMETIC ACTION OF PHENELZINE AND PHENIPRAZINE [PDF]

, 1967
VAN CLINESCHMIDT, Akira Horita
openalex   +1 more source

Use of phenelzine (Nardil) in a general hospital setting.

, 1961
Lawrence W. Woods, David J. Lewis
openalex   +1 more source

Reprogramming the immunologically cold landscape of prostate cancer through MAOA inhibition. [PDF]

J Immunother Cancer
Singh AK, Wu BJ.
europepmc   +1 more source

The Future of Oncology in Psychiatric Medications. [PDF]

J Clin Med
Waszkiewicz N.
europepmc   +1 more source

INFLUENCE OF PRETREATMENT WITH A MONOAMINE OXIDASE INHIBITOR (PHENELZINE) ON THE EFFECTS OF BUPRENORPHINE AND PETHIDINE IN THE CONSCIOUS RABBIT

, 1988
John Edwin Mackenzie, Leonie W. Frank
openalex   +1 more source

Antidepressants in Inflammatory Bowel Disease: : A systematic review [PDF]

, 2017
Macer, Benjamin, Mikocka-Walus, Antonina Anna, Prady, Stephanie Louise   +2 more
core   +2 more sources

The Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge. [PDF]

Neurol Int
Xu M, Zhang Z, Zhang Z, Liu D, Shang Y, Tang C, Wang W, Li H, You B, Ying H, Shen T.   +10 more
europepmc   +1 more source